Holland Capital successfully raises a new private equity fund of EUR 225 million after a swift fundraising period
Amsterdam/Düsseldorf, March 5, 2024 – After a fundraising period of five months, Holland Capital has established its new investment fund, Holland Capital Growth & Buy Out Fund V. There was significant interest from both existing and new investors, leading to the fund being oversubscribed. As a result, a first-and-final closing occurred at the hard cap of EUR 225 million. Investors in this new fund include (international) institutional parties, family offices, and entrepreneurs (many of whom are active in Healthcare and Technology). The fund is classified as an Article 8 fund under the Sustainable Finance Disclosure Regulation (SFDR).
The fund will continue its existing strategy
Holland Capital will deploy the capital for investments in medium-sized Dutch and German companies operating in the Healthcare, Technology, and Agrifood-Tech sectors. This aligns the investment strategy of this fund with its previous funds. With the SFDR Article 8 classification and the related ESG objectives of the fund, Holland Capital reaffirms its ambitions in this regard.
The fund manager aims to realize 15 to 20 platform investments in the coming years with the available capital. Holland Capital benefits from a continuous and robust lead flow in the mentioned sectors. The first planned investments are already in the final stages of ‘due diligence.’
As an active shareholder, Holland Capital adds value by providing not only capital but also knowledge, a network, and hands-on support in the professionalization of the organization and realization of buy-and-build strategies. Over the past 40 years, Holland Capital has supported over 180 entrepreneurs in growing their businesses. Ewout Prins and Hubert Verbeek, managing partners at Holland Capital, state, “We very much look forward to collaborating with entrepreneurs in this fund, creating value by supporting their companies to a next phase.”
Margot Engels, operational partner & CEO at Holland Capital, “We are grateful for the trust of our investors. The overwhelming enthusiasm is a testament to confidence in Holland Capital’s distinctive approach.”
About Holland Capital
For over 40 years, Holland Capital has responsibly and successfully invested in promising Dutch and German SMEs with growth ambitions. The team understands entrepreneurship and aims for an open, sustainable, and professional relationship with the management teams of the invested companies, with the shared goal of achieving growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and recently added Agrifood-Tech sectors. The team is familiar with the dynamics and opportunities in these sectors and has an extensive network.
Following this successful fundraising, Holland Capital’s total assets under management amount to EUR 500 million, and it currently holds 38 companies in its portfolio. For the fund manager, this marks the eleventh and largest fund since the organization’s establishment in 1981.
Highcare expands its services to the mental health sector through the acquisition of Buro MK
Highcare expands its services to the mental health sector through the acquisition of Buro MK Roosendaal / Zutphen, 26th of April 2019 - Highcare acquires Buro MK, an employment agency specialized in the deployment of mental healthcare professionals (GGZ). With this...
Highcare breidt dienstverlening uit naar GGZ-sector door overname Buro MK
Roosendaal/Zutphen, 25 april 2019 – Highcare neemt Buro MK, een uitzendbureau gespecialiseerd in het uitzenden van zorgprofessionals in de geestelijke gezondheidszorg (GGZ), over. Met deze overname breidt Highcare haar dienstverlening uit naar een specifieke...
CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei
CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei Eindhoven, 25 maart 2019 - CytoSMART, de Eindhovense ontwikkelaar en fabrikant van digitale microscopen voor het monitoren van celkweekprocessen, ontvangt een groeifinanciering van 5,2 miljoen euro....
CytoSMART raises 5.2 million euros for further product innovation and growth
CytoSMART raises 5.2 million euros for further product innovation and growth Eindhoven, 25th of March - CytoSMART, the Eindhoven-based company that develops and manufactures digital microscopes for monitoring live cell cultures, has received 5.2 million euros to fund...
ETTU en Wortell fuseren vanuit ambitie beste Microsoft Cloud Solution Partner te worden
ETTU en Wortell fuseren vanuit ambitie beste Microsoft Cloud Solution Partner te worden Amsterdam, 7 maart 2019 - De ICT-dienstverleners Wortell uit Lijnden en ETTU uit Gouda bundelen de krachten en gaan samen verder onder de naam Wortell. Met de fusie wordt een...
Merger ETTU and Wortell reflects ambition to become the best Microsoft Cloud Solution Partner
Merger ETTU and Wortell reflects ambition to become the best Microsoft Cloud Solution Partner Amsterdam, 7 March 2019 - The IT service providers Wortell from Lijnden and ETTU from Gouda join forces and continue together under the name of Wortell. The merger creates a...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl